Full Press Release Details
Fresenius Medical Care AG & Co. KGaA cuts outlook for FY
2022 due to increased headwinds from U.S. labor market situation and global inflation, and withdraws 2025 targets
In the second quarter Fresenius Medical Care experienced increasing
different headwinds that are now expected to negatively impact the Company s earnings development in the second half of FY 2022
to a significant larger degree than anticipated when giving guidance. Earnings development in particular is anticipated to be affected
by increased wage inflation and worsened staff shortages resulting in capacity constraints in North American Health Care Services. Additionally,
the worsening of the macroeconomic environment is expected to result in higher inflation and disruptions in supply chain.
Against this backdrop, Fresenius Medical Care now anticipates for FY
2022, in constant currency and before special items, revenue to grow at the low end of the previously guided low to mid-single digit percentage
range and now assumes net income (attributable to shareholders of Fresenius Medical Care AG & Co. KGaA) to decline around a high teens
Due to uncertainties of the U.S. labor market and macro-economic inflationary
environment, which are assumed to be temporary, Fresenius Medical Care withdraws 2025 targets of compounded annual average increases
in the mid-single-digit percentage range for revenue and in the high-single-digit percentage range for net income (attributable to shareholders
of Fresenius Medical Care AG & Co. KGaA).
EVP | Head of Investor Relations, Strategic Development & Communications
P. +49 6172 609 2601